Publication | Closed Access
DECREASED PLASMA GROWTH HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-Br-α-ERGOCRYPTINE) ADMINISTRATION<sup>1</sup>
202
Citations
0
References
1974
Year
Acromegalic PatientsPlasma Gh LevelsPituitary GlandGrowth HormoneHuman GrowthPhysiologyPharmacologyPharmacotherapyPituitary DiseaseEndocrinologyMedicineSingle Oral DoseReproductive Endocrinology
A single oral dose of 2–Br–α–ergocryptine (CB154) lowers considerably plasma GH levels in 7 acromegalic patients. The effect is present 2 hrs following the ingestion and lasts about 4–5 hrs.